Position in DXCM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$232,676,401
-$32,159,613 QoQ
Shares Held
3,454,735
-18.1% QoQ
Ownership
0.915%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#21
of 966 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CIBC Bancorp USA Inc. holds $1,059,110,818 across 25 Medical Devices names. DXCM ranks #3 (22.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,890,759 | $353,047,470 | |
| 2 | SYK |
Stryker Corp
|
745,832 | $234,817,746 | |
| 3 | DXCM |
Dexcom Inc
This page
|
3,454,735 | $232,676,401 | |
| 4 | MDT |
Medtronic plc
|
1,027,269 | $80,363,252 | |
| 5 | ITGR |
Integer Holdings Corp
|
381,931 | $35,691,450 | |
| 6 | NEOG |
Neogen Corp
|
3,549,006 | $31,905,562 | |
| 7 | BSX |
Boston Scientific Corp
|
706,276 | $30,143,858 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
310,197 | $19,855,709 |
All Filings in DXCM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $232,676,401 | 3,454,735 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $264,836,014 | 4,217,134 | Shares | Defined | 2026-05-12 | |
| 2025-09-30 | $4,606,673 | 68,460 | Shares | Defined | 2025-11-21 | |
| No filing history on record for this holder in this stock. | ||||||